LYCOS RETRIEVER 
Japan
built 649 days ago
NATICK, Mass., May 8 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its TAXUS® Express2™ paclitaxel-eluting coronary stent system in Japan. The product was approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) on March 30; reimbursement has now been granted by the National Health Insurance System, effective May 1.
Source:
MORE ABOUT
Products